Peer-influenced content. Sources you trust. No registration required. This is HCN.
MDLinx
Proper management of benzodiazepine withdrawal requires individualized care plans and close patient monitoring to mitigate potentially severe health risks.
Psychiatry July 30th 2024
Guideline Central
Research presented at the APA 2024 Annual Meeting sheds light on innovative treatments and the multifaceted burden of anxiety disorders, highlighting significant advances in managing GAD and related comorbidities.
Psychiatry May 21st 2024
Medical Professionals Reference (MPR)
Explore the FDA-cleared Modius Stress, offering groundbreaking ease in managing generalized anxiety with daily 30-minute sessions, showing significant reductions in GAD-7 scores in international clinical trials.
Psychiatry May 14th 2024
Medical News Today (MNT)
Delve into the subtleties of anxiety medication management, focusing on individualized treatment plans that balance efficacy with patient safety.
Psychiatry April 2nd 2024
Explore the latest breakthrough in GAD treatment: MM120 demonstrates remarkable, sustained reduction in anxiety symptoms, offering new hope for patients with severe generalized anxiety disorder.
Clinical Pharmacology March 19th 2024
Johns Hopkins Medicine
Johns Hopkins psychiatrists are spearheading a novel educational initiative, ADAP Jr. High, to address the critical gap in middle schoolers’ understanding of anxiety and depression, offering structured lessons and coping strategies to empower young students.
Family Medicine/General Practice March 12th 2024